Ortivus AB held its annual general meeting on 27 May 2026
The meeting decided on discharge from liability, fees, and re-election of the board and auditor. The CEO commented on the 2025 financial year.
See the latest news and media coverage for Ortivus. We track all announcements, press releases, and industry mentions in real time, all in one place.
Provider of prehospital emergency medical systems
ortivus.comLast updated
In short: Ortivus reported an 18% revenue increase in Q1 2026, launched the MobiMed 5 system, and underwent a majority acquisition by Ponderus Invest AB.
The meeting decided on discharge from liability, fees, and re-election of the board and auditor. The CEO commented on the 2025 financial year.
Net sales rose 18% to SEK 21.5 million with EBITDA at SEK 1.7 million. Gross margin improved to 47%. Key events include new CFO, CPO, loan extension, and H&E divestiture.
Ortivus sells its shares for SEK 5.2 million, realising a profit from the SEK 4.0 million investment. Collaboration on MobiMed enRoute continues unchanged.
Zemack brings extensive product management and technology leadership experience from Readly and prior roles. He will lead product vision for the MobiMed platform.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least...
The medical technology company Ortivus reports an ebitda result of +1.7 million kronor (-1.1) for the first quarter of 2026.
Ortivus is pleased to announce the appointment of Matti Zemack as the new Chief Product Officer (CPO). In this strategic role, Zemack will lead the...
Ortivus is enabling increased investment in its growth strategy by further strengthening its financial position with an additional loan of SEK 5 million, following the...
Track Ortivus and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Ortivus and other trending companies.